- Home
- EVM vs LXRX Comparison
EVM vs LXRX Comparison
Compare EVM & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVM
- LXRX
- Stock Information
- Founded
- EVM 2002
- LXRX 1995
- Country
- EVM United States
- LXRX United States
- Employees
- EVM N/A
- LXRX N/A
- Industry
- EVM Finance/Investors Services
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- EVM Finance
- LXRX Health Care
- Exchange
- EVM Nasdaq
- LXRX Nasdaq
- Market Cap
- EVM 217.4M
- LXRX 228.8M
- IPO Year
- EVM N/A
- LXRX 2000
- Fundamental
- Price
- EVM $8.83
- LXRX $0.74
- Analyst Decision
- EVM
- LXRX Buy
- Analyst Count
- EVM 0
- LXRX 4
- Target Price
- EVM N/A
- LXRX $3.67
- AVG Volume (30 Days)
- EVM 55.8K
- LXRX 3.8M
- Earning Date
- EVM 01-01-0001
- LXRX 07-31-2025
- Dividend Yield
- EVM 4.01%
- LXRX N/A
- EPS Growth
- EVM N/A
- LXRX N/A
- EPS
- EVM 0.20
- LXRX N/A
- Revenue
- EVM N/A
- LXRX $31,213,000.00
- Revenue This Year
- EVM N/A
- LXRX N/A
- Revenue Next Year
- EVM N/A
- LXRX N/A
- P/E Ratio
- EVM $47.61
- LXRX N/A
- Revenue Growth
- EVM N/A
- LXRX 1251.21
- 52 Week Low
- EVM $7.67
- LXRX $0.28
- 52 Week High
- EVM $9.59
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- EVM 47.86
- LXRX 59.62
- Support Level
- EVM $8.73
- LXRX $0.64
- Resistance Level
- EVM $8.88
- LXRX $0.75
- Average True Range (ATR)
- EVM 0.07
- LXRX 0.06
- MACD
- EVM 0.01
- LXRX 0.00
- Stochastic Oscillator
- EVM 70.59
- LXRX 68.76
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income, and alternative strategies to institutional investors, both in the United States and internationally.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.